Category: Prevention


Fueling a Revolution: Driving Research Forward

21 October 2020 In Allies & Partnerships, Melanoma Stories, News, Policy, Prevention, Science, Treatment

MRA is powering a revolution in melanoma research. A revolution that is not only benefiting patients with melanoma but also impacting the field of oncology at large.

Read More


A Personal Journey, A Virtual Platform

23 June 2020 In Melanoma Stories, Prevention, Science

Meet Shirin Bajaj, a third-year resident at NYU’s School of Medicine and MRA Dermatology Research Fellow. Learn about her work and MRA's Dermatology Fellowship Award Program.

Read More


Maintaining Momentum in Melanoma Research

8 June 2020 In Allies & Partnerships, News, Policy, Prevention, Science, Treatment

The last decade has been one of substantial progress and hope for many melanoma patients, researchers, and clinicians. With 12 new therapeutic approaches now approved to treat melanoma, many advanced-stage patients are seeing their tumors shrink or disappear, and are experiencing renewed hope for a brighter future.

Read More


Lighting up Melanoma (One Cell at a Time)

18 May 2020 In Allies & Partnerships, Prevention, Science, Treatment

Meet Aditi Sahu, a post-doctoral fellow at Memorial Sloan Kettering Cancer Center, and MRA Dermatology Research Fellow. Learn about her work and MRA's Dermatology Fellowship Award Program.

Read More


Melanoma Research Advances – 2019 in Review

By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 27 January 2020 In Policy, Prevention, Science, Treatment

During 2019, melanoma research continued its rapid pace of advancement, with FDA approval of a new adjuvant therapy treatment option, several first-in-human clinical trials, and significant progress towards earlier intervention.

Read More


2020 Melanoma Mortality Rates Decreasing Despite Ongoing Increase in Incidence

By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 9 January 2020 In News, Prevention, Science, Treatment

Each January, the American Cancer Society (ACS) releases updated estimates about trends in new cancer cases and deaths in its annual report, Cancer Facts and Figures. This report highlights the estimated incidence (number of new cases), prevalence (number of people alive today with a history of cancer), and survival statistics for...

Read More


Brown Skin Too: If You Have Skin, You Can Get Skin Cancer

By Cody R. Barnett, MRA Director of Communications | 6 December 2019 In Melanoma Stories, Prevention

While pervasive, the myth that people of color don’t need to worry about skin cancer, is entirely untrue. And while the rates of skin cancer among people of color are lower than rates for people with lighter skin, low risk doesn’t mean no risk.

Read More


Highlights from the 2019 Scientific Retreat

30 May 2019 In Allies & Partnerships, Events, Melanoma Stories, News, Prevention, Science, Treatment

Over the course of three days, MRA convened over 300 people from across the melanoma research community: patients, doctors, researchers, industry, and government. Participants discussed everything from new treatment approaches such as RNA-based vaccines, strategies to fight back against treatment resistance, and hurdles to testing neo-adjuvant therapies in melanoma.

Read More


Police Lieutenant Tackles Melanoma in Phoenix

By Charles Brodine, MRA Intern | 13 May 2019 In Melanoma Stories, Prevention

After being diagnosed with Stage 3 melanoma, Chris Eyrich is committed to raising awareness about melanoma. He works to raise awareness of the unique occupational hazards faced by people who work primarily outdoors, such as police officers and other public servants.

Read More


Bronze Bodies and Black Lungs: Five Ways the Tanning and Tobacco Industries Use the Same Playbook

By Charles Brodine, MRA Intern | 17 March 2019 In Prevention, Science

Dr. Alan Blum has crusaded against the tobacco industry for 30 years and now he's taking aim at the tanning industry. According to Blum, both the tobacco and tanning industries exploit people in similar ways, by targeting youth, downplaying their own corporate responsibility, infiltrating pop-culture, and indeed, by becoming prolific icons.

Read More


Login

×